The Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2024 covers topics such as:
- The differences in staging between borderline and unresectable locally advanced pancreatic and hepato-biliary cancers
- Identifying patients who will benefit from preoperative therapy prior to surgery
- Identifying patients suitable for a liver transplant
- Identifying patients with resecetable pancreatic cancer who are candidates for a minimally invasive procedure
- Molecular biology of pancreatic and hepato-bilary cancers
- Integrating novel agents in clinical care and clinical trial participation
- Managing neuroendocrine and adeno squamous cell cancers of the pancreas
- The appropriate regimen for first and second line therapy in treating advanced pancreatic cancer and hepato-biliary cancer
The Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2024 brings together:
- Gastroenterologists
- Surgeons
- Laboratory scientists
- Medical and radiation oncologists
- Nurse practitioners
- Physician assistants
- Oncology pharmacists
- Registered nurses
- Oncology nurses and clinical research personnel
The Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2024 will be held in Las Vegas, United States on 07-08 Nov 2024.
